REFERENCES
1. Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72:409-36.
2. Emran TB, Shahriar A, Mahmud AR, et al. Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches. Front Oncol. 2022;12:891652.
4. Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21:3233.
5. Geisslinger F, Müller M, Vollmar AM, Bartel K. Targeting lysosomes in cancer as promising strategy to overcome chemoresistance - a mini review. Front Oncol. 2020;10:1156.
6. Zhitomirsky B, Assaraf YG. Lysosomes as mediators of drug resistance in cancer. Drug Resist Updat. 2016;24:23-33.
7. Chauhan N, Patro BS. Emerging roles of lysosome homeostasis (repair, lysophagy and biogenesis) in cancer progression and therapy. Cancer Lett. 2024;584:216599.
8. Trybus W, Trybus E, Król T. Lysosomes as a target of anticancer therapy. Int J Mol Sci. 2023;24:2176.
9. Cuesta-Casanovas L, Delgado-Martínez J, Cornet-Masana JM, Carbó JM, Clément-Demange L, Risueño RM. Lysosome-mediated chemoresistance in acute myeloid leukemia. Cancer Drug Resist. 2022;5:233-44.
10. Liverani C, De Vita A, Spadazzi C, et al. Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture. Mol Oncol. 2022;16:921-39.
11. Xu Z, He C, Li X, Huang L, Cheng B, Dong S. Glucuronidase-instructed glycopeptide self-assembly for selective killing of cancer cells through lysosomal membrane permeabilization. Angew Chem Int Ed Engl. ;2025:e202420596.
12. Zhitomirsky B, Assaraf YG. Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance. Oncotarget. 2015;6:1143-56.
13. Hu M, Carraway KL 3rd. Repurposing cationic amphiphilic drugs and derivatives to engage lysosomal cell death in cancer treatment. Front Oncol. 2020;10:605361.
14. Keum C, Hong J, Kim D, Lee SY, Kim H. Lysosome-instructed self-assembly of amino-acid-functionalized perylene diimide for multidrug-resistant cancer cells. ACS Appl Mater Interfaces. 2021;13:14866-74.
15. Wang J, Zhou L, Wang H. Harnessing endocytic pH gradients for cascaded formation of intracellular condensates to inhibit autophagy: a pathway to cancer therapy. Nano Today. 2024;57:102317.
16. Chen Y, Yang Z, Wang S, et al. Boosting ROS-mediated lysosomal membrane permeabilization for cancer ferroptosis therapy. Adv Healthc Mater. 2023;12:e2202150.
17. Kim JW, Min DW, Kim D, et al. GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis. Sci Rep. 2023;13:8872.
18. Muhammad P, Hanif S, Li J, et al. Carbon dots supported single Fe atom nanozyme for drug-resistant glioblastoma therapy by activating autophagy-lysosome pathway. Nano Today. 2022;45:101530.
19. Xu S, Wang T, Hu X, et al. A dual chemodrug-loaded hyaluronan nanogel for differentiation induction therapy of refractory AML via disrupting lysosomal homeostasis. Sci Adv. 2025;11:eado3923.
20. Xiang Y, Li N, Liu M, et al. Nanodrugs detonate lysosome bombs. Front Pharmacol. 2022;13:909504.
21. Yan H, Catania C, Bazan GC. Membrane-intercalating conjugated oligoelectrolytes: impact on bioelectrochemical systems. Adv Mater. 2015;27:2958-73.
22. Zhou C, Chia GWN, Yong KT. Membrane-intercalating conjugated oligoelectrolytes. Chem Soc Rev. 2022;51:9917-32.
23. Leifert D, Moreland AS, Limwongyut J, Mikhailovsky AA, Bazan GC. Photoswitchable conjugated oligoelectrolytes for a light-induced change of membrane morphology. Angew Chem Int Ed Engl. 2020;59:20333-7.
24. Limwongyut J, Nie C, Moreland AS, Bazan GC. Molecular design of antimicrobial conjugated oligoelectrolytes with enhanced selectivity toward bacterial cells. Chem Sci. 2020;11:8138-44.
25. Moreland AS, Limwongyut J, Holton SJ, Bazan GC. Structural modulation of membrane-intercalating conjugated oligoelectrolytes decouples outer membrane permeabilizing and antimicrobial activities. Chem Commun. 2023;59:12172-5.
26. Wang B, Fronk SL, Rengert ZD, Limwongyut J, Bazan GC. Conjugated oligoelectrolytes: materials for acceleration of whole cell biocatalysis. Chem Mater. 2018;30:5836-40.
27. Wang B, Wang M, Mikhailovsky A, Wang S, Bazan GC. A membrane-intercalating conjugated oligoelectrolyte with high-efficiency photodynamic antimicrobial activity. Angew Chem Int Ed Engl. 2017;56:5031-4.
28. Du C, Gao D, Gao M, et al. Property regulation of conjugated oligoelectrolytes with polyisocyanide to achieve efficient photodynamic antibacterial biomimetic hydrogels. ACS Appl Mater Interfaces. 2021;13:27955-62.
29. Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Delivery Rev. 2021;176:113851.
30. Lombardo D, Kiselev MA. Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics. 2022;14:543.
31. Wood CA, Han S, Kim CS, et al. Clinically translatable quantitative molecular photoacoustic imaging with liposome-encapsulated ICG J-aggregates. Nat Commun. 2021;12:5410.
32. Ishow E, Clavier G, Miomandre F, Rebarz M, Buntinx G, Poizat O. Comprehensive investigation of the excited-state dynamics of push-pull triphenylamine dyes as models for photonic applications. Phys Chem Chem Phys. 2013;15:13922-39.
33. Rennick JJ, Johnston APR, Parton RG. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotechnol. 2021;16:266-76.
34. Maruoka N, Murata T, Omata N, et al. Effects of chlorpromazine on plasma membrane permeability and fluidity in the rat brain: a dynamic positron autoradiography and fluorescence polarization study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:178-86.
35. Pawlikowska-Pawlęga B, Misiak LE, Jarosz-Wilkołazka A, et al. Biophysical characterization of genistein-membrane interaction and its correlation with biological effect on cells - the case of EYPC liposomes and human erythrocyte membranes. Biochim Biophys Acta. 2014;1838:2127-38.
36. Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene. 2008;27:6434-51.
37. Dou Y, Kawaler EA, Zhou DC, et al.; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic characterization of endometrial carcinoma. Cell. 2020;180:729-48.e26.
38. Song Q, Yang Y, Jiang D, et al. Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues. Nat Commun. 2022;13:4167.
39. Xu S, Hu E, Cai Y, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19:3292-320.
40. Pampaloni F, Reynaud EG, Stelzer EHK. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol. 2007;8:839-45.
41. Zanoni M, Piccinini F, Arienti C, et al. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep. 2016;6:19103.
42. Repnik U, Hafner Česen M, Turk B. Lysosomal membrane permeabilization in cell death: concepts and challenges. Mitochondrion. 2014;19 Pt A:49-57.
43. Qiao L, Hu J, Qiu X, et al. LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles. Autophagy. 2023;19:2837-52.
44. Tan JX, Finkel T. A phosphoinositide signalling pathway mediates rapid lysosomal repair. Nature. 2022;609:815-21.
